Cargando…
Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
INTRODUCTION: Intensive care unit (ICU) patients are predisposed to thromboembolism. Routine prophylactic anticoagulation is widely recommended. Low-molecular-weight heparins, such as enoxaparin, are increasingly used because of predictable pharmacokinetics. This study aims to determine the subcutan...
Autores principales: | Robinson, Sian, Zincuk, Aleksander, Strøm, Thomas, Larsen, Torben Bjerregaard, Rasmussen, Bjarne, Toft, Palle |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887151/ https://www.ncbi.nlm.nih.gov/pubmed/20298591 http://dx.doi.org/10.1186/cc8924 |
Ejemplares similares
-
A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial
por: Robinson, Sian, et al.
Publicado: (2013) -
Effective dosage of enoxaparin for intensive care patients
por: Robinson, S, et al.
Publicado: (2013) -
A feasible strategy for preventing blood clots in critically ill patients with acute kidney injury (FBI): study protocol for a randomized controlled trial
por: Robinson, Sian, et al.
Publicado: (2014) -
Predictors of renal recovery in critically ill patients with AKI: observations from the ongoing FBI clinical trial
por: Robinson, S, et al.
Publicado: (2015) -
Diagnostic value of prehospital arterial blood gas measurements – a randomised controlled trial
por: Zwisler, Stine T., et al.
Publicado: (2019)